Estrogen related receptor alpha triggers the migration and invasion of endometrial cancer cells via up regulation of TGFB1

References

• Bell DW. Novel genetic targets in endometrial cancer. Expert Opin Ther Tar. 2014;18:725–30. doi:10.1517/14728222.2014.909414.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Kurra V, Krajewski KM, Jagannathan J, et al. Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging. 2013;13:113–22. doi:10.1102/1470-7330.2013.0011.
   PubMed Web of Science ®Google Scholar
• van der Steen MJ, de Waal YR, Westermann A, et al. An impressive response to pazopanib in a patient with metastatic endometrial carcinoma. Neth J Med. 2016;74:410–3.
   PubMed Web of Science ®Google Scholar
• Thanapprapasr D, Thanapprapasr K. Molecular Therapy as a Future Strategy in Endometrial Cancer. Asian Pac J Cancer P. 2013;14:3419–23. doi:10.7314/APJCP.2013.14.6.3419.
   PubMedGoogle Scholar
• Kent CN, Reed IKG. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs. Clin Transl Oncol. 2016;18:1056–61. doi:10.1007/s12094-016-1492-2.
   PubMed Web of Science ®Google Scholar
• Pessoa JN, Freitas ACL, Guimaraes RA, et al. Endometrial Assessment: When is it Necessary? J Clin Med Res. 2014;6:21–5.
   PubMedGoogle Scholar
• Razzaque MA, Masuda N, Maeda Y, et al. Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition. Gene. 2004;340:275–82. doi:10.1016/j.gene.2004.07.010.
   PubMed Web of Science ®Google Scholar
• Giguere V. Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors. Endocr Rev. 2008;29:677–96. doi:10.1210/er.2008-0017.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Miki Y, Moriya T, et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res. 2004;64:4670–6. doi:10.1158/0008-5472.CAN-04-0250.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Inoue S, Urano T, et al. Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer. Clin Genitourin Canc. 2016;14:298–303. doi:10.1016/j.clgc.2016.01.011.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Kinoshita Y, Hosokawa K, et al. Function of estrogen-related receptor alpha in human endometrial cancer. J Clin Endocrinol Metab. 2006;91:1573–7. doi:10.1210/jc.2005-1990.
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Sato E. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J Steroid Biochem Mol Biol. 2009;116:71–5. doi:10.1016/j.jsbmb.2009.04.012.
   PubMed Web of Science ®Google Scholar
• Gao M, Sun P, Wang J, et al. Expression of estrogen receptor-related receptor isoforms and clinical significance in endometrial adenocarcinoma. Int J Gynecol Cancer. 2006;16:827–33. doi:10.1111/j.1525-1438.2006.00527.x.
   PubMed Web of Science ®Google Scholar
• Seo E, Lim JS, Jun JB, et al. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing. J Transl Med. 2017;15:35. doi:10.1186/s12967-017-1145-4.
   Web of Science ®Google Scholar
• Fichtner-Feigl S, Strober W, Kawakami K, et al. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12:99–106. doi:10.1038/nm1332.
   PubMed Web of Science ®Google Scholar
• Setrerrahmane S, Xu H. Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer. 2017;16:153. doi:10.1186/s12943-017-0721-9.
   PubMed Web of Science ®Google Scholar
• Chopra V, Dinh TV, Hannigan EV. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol. 1997;123:167–72.
   PubMed Web of Science ®Google Scholar
• Daley-Brown D, Oprea-Ilies GM, Lee R, et al. Molecular cues on obesity signals, tumor markers and endometrial cancer. Horm Mol Biol Clin Investig. 2015;21:89–106.
   PubMed Web of Science ®Google Scholar
• Matsushima H, Mori T, Ito F, et al. Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer. Oncotarget. 2016;7:34131–48. doi:10.18632/oncotarget.9151.
   PubMedGoogle Scholar
• Ding SJ, Tang ZH, Jiang YJ, et al. IL-8 Is Involved in Estrogen-Related Receptor alpha-Regulated Proliferation and Migration of Colorectal Cancer Cells. Digest Dis Sci. 2017;62:3438–46. doi:10.1007/s10620-017-4779-4.
   PubMed Web of Science ®Google Scholar
• Wu YM, Chen ZJ, Liu H, et al. Inhibition of ERRalpha suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Oncotarget. 2015;6:25588–601.
   PubMedGoogle Scholar
• Carnesecchi J, Forcet C, Zhang L, et al. ERRalpha induces H3K9 demethylation by LSD1 to promote cell invasion. Proc Natl Acad Sci U S A. 2017;114:3909–14. doi:10.1073/pnas.1614664114.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang K, Li Y, et al. Estrogen-related receptor alpha participates transforming growth factor-beta (TGF-beta) induced epithelial-mesenchymal transition of osteosarcoma cells. Cell Adh Migr. 2017;11:338–46. doi:10.1080/19336918.2016.1221567.
   PubMed Web of Science ®Google Scholar
• Katsuno Y, Lamouille S, Derynck R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol. 2013;25:76–84. doi:10.1097/CCO.0b013e32835b6371.
   PubMed Web of Science ®Google Scholar
• Horiguchi M, Ota M, Rifkin DB. Matrix control of transforming growth factor-beta function. J Biochem. 2012;152:321–9. doi:10.1093/jb/mvs089.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Seki T, Okazaki K. TGF-beta signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. Journal of Gastroenterology. 2014;49:971–81. doi:10.1007/s00535-013-0910-2.
   PubMed Web of Science ®Google Scholar
• Pathil A, Mueller J, Ludwig JM, et al. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-beta1/Smad2/3 signalling. Br J Pharmacol. 2014;171:5113–26.
   PubMed Web of Science ®Google Scholar